Search

Your search keyword '"D. Moreira"' showing total 107 results

Search Constraints

Start Over You searched for: Author "D. Moreira" Remove constraint Author: "D. Moreira" Topic medicine.medical_specialty Remove constraint Topic: medicine.medical_specialty
107 results on '"D. Moreira"'

Search Results

1. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial

2. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

3. Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination

4. Sensory Afferent Renal Nerve Activated Gαi2 Subunit Proteins Mediate the Natriuretic, Sympathoinhibitory and Normotensive Responses to Peripheral Sodium Challenges

5. Postural alert system for sitting position

6. Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults

7. Abstract P281: Vascular Remodeling And Impaired Vascular Smooth Muscle Cell Plasticity In Age And Sex-dependent Hypertension

8. Abstract P189: AT 1 R-Dependent Blood-Brain Barrier Disruption Precedes Neuroinflammation In Age-Dependent Hypertension

9. Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine

10. Inhibition of microglial activation in rats attenuates paraventricular nucleus inflammation in Gαi 2 protein‐dependent, salt‐sensitive hypertension

11. Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003)

12. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

13. Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-up

14. Sympathetic Regulation of the NCC (Sodium Chloride Cotransporter) in Dahl Salt-Sensitive Hypertension

15. Abstract MP05: Pvn-specific Microgliosis And Inflammation Precedes Sympathoexcitation In gαI 2 Protein-dependent, Salt-sensitive Hypertension

16. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

17. Óbitos e internações decorrentes de intoxicações por medicamentos com prescrição e isentos de prescrição, no Brasil

18. Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women☆

19. Pancreatic adenosquamous carcinoma, a rare entity: report of four cases

20. Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial

21. Immunogenicity and safety of concomitant administration of meningococcal serogroup B (4CMenB) and serogroup C (MenC-CRM) vaccines in infants: A phase 3b, randomized controlled trial

24. Abstract 086: Pvn-Specific Microgliosis Drives Inflammation in G-Alpha-i 2 Protein Dependent Salt Sensitive Hypertension and Gnai2 Snps Correlate With Essential Hypertension

25. A selective impairment in the mechanosensitive afferent renal nerve‐mediated sympathoinhibitory reno‐renal reflex contributes to age‐related hypertension

26. Clinical presentation, aetiology and outcomes of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study

27. Parada cardiaca durante cesárea de parto gemelar

28. Metabolic Alterations in Experimental Autoimmune Encephalomyelitis in Mice: Effects of Prior Physical Exercise

30. Adrenergic regulation of the NCC in the development and maintenance of Dahl Salt‐Sensitive Hypertension occurs via a WNK/SPAK/OxSR1 pathway

31. In the View of Endothelial Microparticles: Novel Perspectives for Diagnostic and Pharmacological Management of Cardiovascular Risk during Diabetes Distress

32. Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age

33. Low coverage of HPV vaccination in the national immunization programme in Brazil: Parental vaccine refusal or barriers in health-service based vaccine delivery?

34. P1.17-27 Stereotactic Radiotherapy for Primary Lung Tumors: The Influence of Size

35. Phase III, randomized controlled trial in girls 9-15 years old to evaluate lot consistency of a novel nine-valent human papillomavirus L1 virus-like particle vaccine

37. P5121Stratification of hemorrhagic risk: the ATRIA bleeding score in patients with acute coronary syndrome undergoing percutaneous coronary intervention

40. Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trials

41. Endothelinergic Contractile Hyperreactivity in Rat Contralateral Carotid to Balloon Injury: Integrated Role for ETB Receptors and Superoxide Anion

42. Crystal Methamphetamine Use and HIV Transmission Among Gay and Bisexual Men

43. Incidence, Clearance, and Disease Progression of Genital Human Papillomavirus Infection in Heterosexual Men

44. Safety profile of the 9-valent HPV vaccine : a combined analysis of 7 phase III clinical trials

45. Poster session 2

47. HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia

48. Prevalence of and Risk Factors for Human Papillomavirus (HPV) Infection Among HIV-Seronegative Men Who Have Sex With Men

49. External Genital Human Papillomavirus Prevalence and Associated Factors Among Heterosexual Men on 5 Continents

50. Poster session II * Thursday 9 December 2010, 14:00-18:00

Catalog

Books, media, physical & digital resources